Early eradication of pseudomonas aeruginosa in patients with cystic fibrosis

Bridget Stuart, Jenny H. Lin, Peter J. Mogayzel

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Pseudomonas aeruginosa (Pa) is the predominant organism infecting the airways of patients with cystic fibrosis (CF). This organism has an armamentarium of survival mechanisms that allows it to survive in the CF airway. Since colonization and chronic infection with Pa is associated with poorer lung function and increased morbidity and mortality, therapies that can prevent infection could significantly improve the lives of patients with CF. Numerous studies have examined the effects of treatment on the eradication of Pa as a means to ameliorate disease. This article outlines the pathophysiology and clinical implication of Pa acquisition, and reviews the existing treatment regimens aimed at early eradication of Pa in patients with CF.

Original languageEnglish (US)
Pages (from-to)177-184
Number of pages8
JournalPaediatric Respiratory Reviews
Volume11
Issue number3
DOIs
StatePublished - Sep 2010

Fingerprint

Cystic Fibrosis
Pseudomonas aeruginosa
Infection
Therapeutics
Morbidity
Lung
Survival
Mortality

Keywords

  • Colonization
  • Cystic fibrosis
  • Eradication therapy
  • Inhaled tobramycin
  • Pseudomonas aeruginosa

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine

Cite this

Early eradication of pseudomonas aeruginosa in patients with cystic fibrosis. / Stuart, Bridget; Lin, Jenny H.; Mogayzel, Peter J.

In: Paediatric Respiratory Reviews, Vol. 11, No. 3, 09.2010, p. 177-184.

Research output: Contribution to journalArticle

Stuart, Bridget ; Lin, Jenny H. ; Mogayzel, Peter J. / Early eradication of pseudomonas aeruginosa in patients with cystic fibrosis. In: Paediatric Respiratory Reviews. 2010 ; Vol. 11, No. 3. pp. 177-184.
@article{87023950e6d945f2a3ad1c78004c6717,
title = "Early eradication of pseudomonas aeruginosa in patients with cystic fibrosis",
abstract = "Pseudomonas aeruginosa (Pa) is the predominant organism infecting the airways of patients with cystic fibrosis (CF). This organism has an armamentarium of survival mechanisms that allows it to survive in the CF airway. Since colonization and chronic infection with Pa is associated with poorer lung function and increased morbidity and mortality, therapies that can prevent infection could significantly improve the lives of patients with CF. Numerous studies have examined the effects of treatment on the eradication of Pa as a means to ameliorate disease. This article outlines the pathophysiology and clinical implication of Pa acquisition, and reviews the existing treatment regimens aimed at early eradication of Pa in patients with CF.",
keywords = "Colonization, Cystic fibrosis, Eradication therapy, Inhaled tobramycin, Pseudomonas aeruginosa",
author = "Bridget Stuart and Lin, {Jenny H.} and Mogayzel, {Peter J.}",
year = "2010",
month = "9",
doi = "10.1016/j.prrv.2010.05.003",
language = "English (US)",
volume = "11",
pages = "177--184",
journal = "Paediatric Respiratory Reviews",
issn = "1526-0550",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Early eradication of pseudomonas aeruginosa in patients with cystic fibrosis

AU - Stuart, Bridget

AU - Lin, Jenny H.

AU - Mogayzel, Peter J.

PY - 2010/9

Y1 - 2010/9

N2 - Pseudomonas aeruginosa (Pa) is the predominant organism infecting the airways of patients with cystic fibrosis (CF). This organism has an armamentarium of survival mechanisms that allows it to survive in the CF airway. Since colonization and chronic infection with Pa is associated with poorer lung function and increased morbidity and mortality, therapies that can prevent infection could significantly improve the lives of patients with CF. Numerous studies have examined the effects of treatment on the eradication of Pa as a means to ameliorate disease. This article outlines the pathophysiology and clinical implication of Pa acquisition, and reviews the existing treatment regimens aimed at early eradication of Pa in patients with CF.

AB - Pseudomonas aeruginosa (Pa) is the predominant organism infecting the airways of patients with cystic fibrosis (CF). This organism has an armamentarium of survival mechanisms that allows it to survive in the CF airway. Since colonization and chronic infection with Pa is associated with poorer lung function and increased morbidity and mortality, therapies that can prevent infection could significantly improve the lives of patients with CF. Numerous studies have examined the effects of treatment on the eradication of Pa as a means to ameliorate disease. This article outlines the pathophysiology and clinical implication of Pa acquisition, and reviews the existing treatment regimens aimed at early eradication of Pa in patients with CF.

KW - Colonization

KW - Cystic fibrosis

KW - Eradication therapy

KW - Inhaled tobramycin

KW - Pseudomonas aeruginosa

UR - http://www.scopus.com/inward/record.url?scp=77955413607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955413607&partnerID=8YFLogxK

U2 - 10.1016/j.prrv.2010.05.003

DO - 10.1016/j.prrv.2010.05.003

M3 - Article

C2 - 20692633

AN - SCOPUS:77955413607

VL - 11

SP - 177

EP - 184

JO - Paediatric Respiratory Reviews

JF - Paediatric Respiratory Reviews

SN - 1526-0550

IS - 3

ER -